Benzodiazepine receptor distribution and diazepam binding in schizophrenia: An exploratory study

Psychiatry Research - Neuroimaging

Volumn 68, Issue 2-3, 1997, Pages 125-131

  Schröder, Johannes ^a   Bubeck, Bernd ^a   Demisch, Sibylle ^a   Sauer, Heinrich ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

diazepam; GABA; schizophrenia; SPECT

Indexed keywords

BENPERIDOL; BENZODIAZEPINE; BIPERIDEN; DIAZEPAM; IODINE 123; IOMAZENIL; PROMETHAZINE;

ADULT; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; FRONTAL LOBE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR BINDING; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BENZODIAZEPINES; BINDING SITES; CHRONIC DISEASE; DIAZEPAM; FLUMAZENIL; FRONTAL LOBE; GROWTH HORMONE; HUMANS; HYDROCORTISONE; OCCIPITAL LOBE; RECEPTORS, GABA-A; SCHIZOPHRENIA; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031557116     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(96)02843-0     Document Type: Article

References (29)

1. Abi-Dargham, A., Gandelman, M., Zoghbi, S., Laruelle, M., Baldwin, R.M., Randall, P., Zea-Ponce, Y., Charney, D.S., Hoffer, P.B. and Innis, R.B. (1995) Reproducibility of SPECT measurement of benzodiazepine receptor in human brain with iodine-123-iomazenil. J Nucl Med 36, 167-175.
2. Andreasen, N.C., Rezai, K., Alliger, R., Swayze, V.W. 11, Flaum, M., Kirchner, P., Cohen, G. and O'Leary, D.S. (1992) Hypofrontality in neuroleptic naive patients and in patients with chronic schizophrenia: assessment with xenon 133 single photon emission tomography and the tower of London test. Arch Gen Psychiatry 49, 943-958.
3. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders. 3rd edition. American Psychiatric Press, Washington, DC.
4. Bartenstein, P., Ludolph, A., Schober, O., Lottes, G., Scheidhauer, K., Sciuk, J. and Beer, H.-F. (1991) Benzodiazepine receptors and cerebral blood flow in partial epilepsy. Eur J Nucl Med 18, 111-118.
5. Beckmann, H. and Haas, S. (1980) High dose diazepam in schizophrenia. Psychopharmacology 71, 79-82.
6. Beer, H.F., Bläuenstein, P.A., Hasler, P.A., Delaloye, B., Riccabona, G., Bangerl, I., Hunkeler, W., Bonetti, E.P., Pieri, L. and Richards, J.G. (1990) In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 31 (6), 1007-1014.
7. Benes, F., Vincent, S.L., Alsterberg, G., Bird, E.D. and SanGiovanni, J.P. (1992) Increased GABA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12, 924-929.
8. Buchsbaum, M.S. (1990) The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull 16, 379-389.
9. Busatto, G.F., Pilowsky, L.S., Costa, D.C., Ell, P.J., Davis, A.S., Lucey, J.V. and Robert, R.W. Reduced in vivo benzodiazepine receptor binding correlates with severity of psychotic symptoms in schizophrenia. Am J Psychiatry (in press).
10. Dauth, J., Höll, K. and Deisenhammer, E. (1990) Time curves of radioactivity in plasma after injection of jomazenil Ro 16-0154. In: Schubiger, P.A. and Hasler, P.H. (Eds.), Jomazenil and Other Brain Receptor Tracers for SPECT. Editiones Roche, Basel.
11. Delini-Stula, A. and Berdah-Tordjman, D. (1995) Benzodiazepines and GABA hypothesis of schizophrenia. J Psychopharmacol 9, 57-63.
12. 11C-raclopride and positron emission tomography. J Neurosci 12, 3773-3780.
13. Goldberg, H.L. and Finnerty R. (1982) Comparison of buspirone in two separate studies. J Clin Psychiatry 43, 87-91.
14. 3H-muscimol binding sites increased in autopsied brains of chronic schizophrenics. LifeSci 40, 259-266.
15. Höll, K., Deisenhammer, E., Dauth, J., Carmann, H. and Schubiger, P.A. (1989) Imaging benzodiazepine receptors in the human brain by single photon emission computed tomography (SPECT). Nucl Med Biol 8, 759-763.
16. Hommer, D.W., Matsuo, V., Wolkowitz, O., Chrousos, G., Greenblatt, D.J., Weingartner, H. and Paul, S.M. (1986) Benzodiazepine sensitivity in normal human subjects. Arch Gen Psychiatry 43, 542-551.
17. Jaspert, A. and Ebert, D. (1994) Benzodiazepinmonotherapie bei akuten Schizophrenien. Nervenarzt 65, 62-65.
18. Overall, J.E. and Gorham, D.R. (1962) The Brief Psychiatric Rating Scale, Psychol Rep 10, 799-812.
19. Reynolds, G., Czudek, C. and Andrews, H.B. (1990) Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol Psychiatry 27, 1038-1044.
20. Savic, I., Roland P., Sedvall, G., Persson, A., Pauli, S. and Widen, L. (1988) In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 11, 863-866.
21. Schröder, J., Bubeck, B., Roelcke, U., Jauss, M., Schubiger, P.A. and Sauer, H. (1993) A new methodological approach for the imaging of cerebral benzodiazepine receptors in schizophrenia: preliminary results of a single photon emission tomography study with iomazenil. In: Maurer, K. (Ed.), Imaging of the Brain in Psychiatry and Related Fields. Springer-Verlag, Berlin.
22. Schröder, J., Buchsbaum, M.S., Siegel, B.V., Geider, F.J., Lohr, J., Tang, Ch., Wu, J. and Potkin, S.G. (1996) Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophr Res 19, 41-53.
23. Sczesni, B., Schröder, J. and Becker, H. (1991) Das neuroleptische maligne Syndrom. Wien Klin Wochenschr 103, 1-7.
24. 3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychosis? Neurochem Res 18, 219-223.
25. Strauss, J.S. and Carpenter, W.T. Jr. (1974) The prediction of outcome in schizophrenia. II. Relationship between predictor and outcome variables. Arch Gen Psychiatry 31, 37-42.
26. Tamminga, C.A., Thaker, G.K., Buchanon, R., Kirkpatrick, B., Alphs, L.D., Chase, T.N. and Carpenter, W.T. (1992) Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 49, 522-530.
27. van Kammen, D.P., Guidotti, A., Kelley, M.E., Gurklis, J., Guarneri, P., Gilbertson, M.W., Yao, J.K., Peters, J. and Costa, E. (1993) CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationships. Biol Psychiatry 34, 515-522.
28. Wetzel, H., Heuser, I. and Benkert, O. (1988) Benzodiazepines for catatonic symptoms, stupor, and mutism. Pharmacopsychiatry 21, 394-395.
29. 123I Iomazenil in healthy human subjects. Psychiatry Res Neuroimaging 45, 67-77.